Question explored with the scientific record
Conversation so far
- 1 is there an insulin reserve in the body
- 2 How do scientists measure insulin reserve in people?
Answered on this page ↓
How do scientists measure insulin reserve in people?
The short version: scientists measure insulin reserve by stimulating the beta cells and then measuring C-peptide, a byproduct of insulin production that is not cleared by the liver, giving a cleaner read on what the pancreas actually secreted.
The core method is the glucagon stimulation test. You inject 1 mg of glucagon and measure C-peptide in the blood 6 minutes later [2]. Glucagon forces the beta cells to release their stored insulin, and C-peptide is the marker because insulin itself gets heavily filtered by the liver. A 6-minute C-peptide below about 0.6 nmol/L (fasting) signals a severely depleted reserve [2]. The test is sensitive to the person's recent meal and blood sugar: a postprandial state can boost the response by about 60%, so the cutoff must be adjusted upward to roughly 1.0 nmol/L [2].
A less invasive alternative is the urinary C-peptide creatinine ratio. One study of 77 people with type 2 diabetes found that a single urine sample taken 2 hours after a meal correlated well with serum C-peptide (r = 0.64) and was more reproducible (26% vs 27% variation) [1]. This avoids repeated blood draws but still requires a standardized meal.
The most precise research method is the minimal model of C-peptide kinetics during an intravenous glucose tolerance test. This uses frequent blood sampling and mathematical modeling to separate first-phase from second-phase insulin secretion and to estimate how much insulin the liver extracts [3]. In one study, first-phase secretion sensitivity was 61 pM·min⁻¹·mg⁻¹·dL and hepatic extraction at fasting was 63% [3].
| Method | What it measures | Key cutoff or value | Invasiveness |
|---|---|---|---|
| Glucagon stimulation test | 6-min C-peptide after 1 mg glucagon | <0.6 nmol/L fasting = low reserve [2] | Blood draw |
| Urinary C-peptide creatinine ratio | C-peptide in urine 2h post-meal | Correlates r=0.64 with serum [1] | Urine sample |
| IVGTT with minimal model | First- and second-phase secretion, hepatic extraction | First-phase sensitivity 61 pM·min⁻¹·mg⁻¹·dL [3] | IV line, frequent blood draws |
The evidence here does not include a direct comparison of these methods head-to-head in the same people, so the practical choice depends on what you need: the glucagon test for a quick clinical answer, the urine test for convenience, and the IVGTT model for research precision.
My call: the glucagon stimulation test with C-peptide measurement is the standard clinical method, and the evidence supports its use with proper meal standardization. Confidence: high.
Sources used 3
-
Validation of a single‐sample urinary C‐peptide creatinine ratio as a reproducible alternative to serum C‐peptide in patients with Type 2 diabetes
This study validates the urinary C-peptide creatinine ratio as a reliable and non-invasive alternative to serum C-peptide measurement in assessing endogenous insulin secretion in patients with Type 2 diabetes, even in the presence of moderate renal impairment.
DOI: 10.1111/j.1464-5491.2011.03428.x -
Practical aspects in performing the glucagon test in the measurement of C-peptide secretion in diabetic patients
In insulin-treated diabetic patients, the study demonstrates that a postprandial state markedly enhances glucagon-stimulated C-peptide secretion compared with fasting, while hypoglycemia strongly suppresses the response; these findings underscore the need to standardize pre-test…
DOI: 10.3109/00365518609083681 -
Insulin Secretion and Hepatic Extraction in Humans by Minimal Modeling of C-Peptide and Insulin Kinetics
This study introduces a noninvasive method for measuring insulin secretion and hepatic insulin extraction in humans using a minimal model of C-peptide and insulin kinetics during an intravenous glucose tolerance test (IVGTT).
DOI: 10.2337/diab.37.2.223